Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus

Sponsor
University of Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT05379725
Collaborator
(none)
40
1
2
33.1
1.2

Study Details

Study Description

Brief Summary

This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE).

Condition or Disease Intervention/Treatment Phase
  • Other: Mediterranean Dietary Pattern
  • Other: High Fermented Food Dietary Pattern
N/A

Detailed Description

Given the demonstrated beneficial effects of the Mediterranean dietary pattern in autoimmune disease and the potential benefit of a high-fermented-food diet on inflammatory profiles, we aim to determine the feasibility and relative benefit of a Mediterranean dietary pattern versus a high-fermented-food diet on inflammatory markers and clinical outcomes in individuals with SLE. The primary aim of the study is to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with SLE. Secondary aims will determine the effects of the Mediterranean dietary pattern and a high-fermented-food diet on attenuating inflammation and disease activity in individuals with SLE. This is a 4-month randomized controlled trial with a 1-month baseline of usual diet and 3-month intervention. Participants will complete the online DHQ III and diet adherence questionnaires monthly. Blood will be obtained at randomization and at the end of the intervention period for analysis of inflammatory cytokines. Dietary intake during baseline and intervention will be assessed by 5, ASA 24-h dietary recalls.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation and Disease Activity in Systemic Lupus Erythematosus
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
May 4, 2025
Anticipated Study Completion Date :
May 4, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mediterranean diet

Participants will receive diet education on adherence to a Mediterranean dietary pattern.

Other: Mediterranean Dietary Pattern
The Mediterranean dietary pattern includes whole or minimally processed foods with a high intake of vegetables, fruits, whole grains, fish, and olive oil.

Experimental: Fermented food

Participants will receive diet education on adherence to a high fermented food dietary pattern.

Other: High Fermented Food Dietary Pattern
Fermented foods such as yogurt, kefir, fermented cottage cheese, fermented vegetables, vegetable brine drinks, kombucha, other fermented non-alcoholic drinks, and other foods will be recommended.

Outcome Measures

Primary Outcome Measures

  1. Adherence - Mediterranean Diet [baseline, month 1, 2 and 3]

    Percent of participants achieving 'good to very good adherence') as assessed by the 14-day Mediterranean diet questionnaire (MEDAS) score

  2. Adherence - Fermented Food Diet [baseline, month 1, 2, and 3]

    Percent of participants achieving > 5 servings of fermented foods per day

Secondary Outcome Measures

  1. Diet Quality [baseline, month 3]

    Healthy Eating Index 2015 score (0 minimum to 100 maximum). Higher values indicate better diet quality.

  2. Systemic Lupus Erythematosus Disease Activity [baseline, month 3]

    Systemic Lupus Erythematosus disease activity using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score (0 minimum and 105 maximum, with higher scores representing higher disease activity.

  3. ESR [baseline, month 3]

    Erythrocyte sedimentation rate

  4. hsCRP [baseline, month 3]

    high-sensitivity C-reactive protein

  5. anti-dsDNA [baseline, month 3]

    Anti-double stranded DNA

  6. Cytokine profile [baseline, month 3]

    Cytokines profile e.g., interleukin-18 (IL-18), tumor necrosis factor (TNF), IL-6, IL-2, IL-10

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Able to provide informed consent and undertake study questionnaire completion in English.

  • Meet SLE diagnostic criteria.

  • Be willing and able to comply with all the study-related procedures.

  • Stable immunosuppression regimen not expected to change over the course of the study.

Exclusion Criteria:
  • Pregnant or planning pregnancy within the duration of the interventional study.

  • Currently following a vegetarian/vegan diet.

  • Allergy/sensitivity to gluten, soy, or cow's milk.

  • Self-disclosure of lactose intolerance

  • Inability to comply with the study procedures.

  • Baseline dietary fiber intake > 30 g/day

  • MEDAS score at baseline > 5

  • Baseline consumption of > 2 servings per day of fermented foods

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Florida/UF Health Gainesville Florida United States 32611

Sponsors and Collaborators

  • University of Florida

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT05379725
Other Study ID Numbers:
  • IRB202200703
First Posted:
May 18, 2022
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Florida
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2022